NCT06035757CompletedPhase 4
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
The Effect of Administration of Sugammadex on the Occurrence of Emergence Agitation in Pediatric Strabismus Surgery-prospective Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 15 Jul 2026
Brief summary (registry, in English)
The present trial conducted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incidence of emergence agitation (EA) comparing to neostigmine
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 76 (actual)
- First submitted
- 6 Sept 2023
- Start date
- 1 Dec 2023
- Primary completion date
- 13 Mar 2026
- Lead sponsor
- Konkuk University Medical Center
- NCT number
- NCT06035757
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 76
- From 1 Dec 2023 to the primary completion date, 13 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- myasthenia gravis or other neuromuscular disorders
- history of drug allergy
- cardiovascular disease or arrhythmia
Other
- ASA classification 3 or more
- impaired liver function
- impaired kidney function
Who the study is looking for
- Patients scheduled elective strabismus surgery aged 4-7 with American Society of Anesthesiologists (ASA) classification 1-3.
Age in the registry: 4 years to 7 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Konkuk University Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.